Rockwell Medical (RMTI) EBT Margin Growth (1y) (2011 - 2026)
Rockwell Medical (RMTI) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Rockwell Medical | 31.73 Mn | 6.93 Mn | 3.24 Mn | 236.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,585.00 |
| Mar 31, 2026 | -3,184.00 |
| Dec 31, 2025 | -749.00 |
| Sep 30, 2025 | -1,842.00 |
| Jun 30, 2025 | -1,653.00 |
| Mar 31, 2025 | -210.00 |
| Dec 31, 2024 | 579.00 |
| Sep 30, 2024 | 1,437.00 |
| Jun 30, 2024 | 1,912.00 |
| Mar 31, 2024 | 143.00 |
| Dec 31, 2023 | 252.00 |
| Sep 30, 2023 | 1,341.00 |
| Jun 30, 2023 | 785.00 |
| Mar 31, 2023 | 3,536.00 |
| Dec 31, 2022 | 4,503.00 |
| Sep 30, 2022 | 2,500.00 |
| Jun 30, 2022 | 2,890.00 |
| Mar 31, 2022 | 566.00 |
| Dec 31, 2021 | 481.00 |
| Sep 30, 2021 | 71.00 |